NAT1 and colon adenocarcinoma: In order to examine further indicators that could be used to predict the prognosis of COAD patients, we performed survival analysis based on combinations of NAT1 mRNA expression and methylation of each CpG site, and accordingly found that seven such combinations were significantly associated with OS in COAD patients (P < 0.05) (Figures 4A–G).